TTF-1 expression in breast carcinoma: An unusual but real phenomenon

Histopathology

Volumn 64, Issue 4, 2014, Pages 504-511

  Ni, Yun Bi ^a   Tsang, Julia Y S ^a   Shao, Mu Min ^b   Chan, Siu Ki ^c   Tong, Joanna ^a   To, Ka Fai ^a   Tse, Gary M ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^c KWONG WAH HOSPITAL   (Hong Kong)

Author keywords

Breast carcinoma; Pulmonary carcinoma; TTF 1

Indexed keywords

BREAST CARCINOMA; PULMONARY CARCINOMA; TTF-1;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CELL NUCLEUS; COHORT STUDIES; CYTOPLASM; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84895067495     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12287     Document Type: Article

References (18)

1. Lazzaro D, Price M, de Felice M et al. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 1991; 113; 1093-1104.
2. Ordóñez NG. Value of thyroid transcription factor-1 immunostaining in tumor diagnosis: a review and update. Appl. Immunohistochem. Mol. Morphol. 2012; 20; 429-444.
3. Compérat E, Zhang F, Perrotin C et al. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectalorigin. Mod. Pathol. 2005; 18; 1371-1376.
4. Matoso A, Singh K, Jacob R et al. Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors. Appl. Immunohistochem. Mol. Morphol. 2010; 18; 142-149.
5. Ye J, Findeis-Hosey JJ, Yang Q et al. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung. Appl. Immunohistochem. Mol. Morphol. 2011; 19; 313-317.
6. Penman D, Downie I, Roberts F. Positive immunostaining for thyroid transcription factor-1 in primary and metastatic colonic adenocarcinoma: a note of caution. J. Clin. Pathol. 2006; 59; 663-647.
7. Xu B, Thong N, Tan D et al. Expression of thyroid transcription factor-1 in colorectal carcinoma. Appl. Immunohistochem. Mol. Morphol. 2010; 18; 244-249.
8. Yamamoto J, Ohshima K, Nabeshima K et al. Comparative study of primary mammary small cell carcinoma, carcinoma with endocrine features and invasive ductal carcinoma. Oncol. Rep. 2004; 11; 825-831.
9. Robens J, Goldstein L, Gown AM et al. Thyroid transcription factor-1 expression in breast carcinomas. Am. J. Surg. Pathol. 2010; 34; 1881-1885.
10. Pan CC, Chen PC, Tsay SH et al. Cytoplasmic immunoreactivity for thyroid transcription factor-1 in hepatocellular carcinoma: a comparative immunohistochemical analysis of four commercial antibodies using a tissue array technique. Am. J. Clin. Pathol. 2004; 121; 343-349.
11. Gokden M, Shinde A. Recent immunohistochemical markers in the differential diagnosis of primary and metastatic carcinomas of the liver. Diagn. Cytopathol. 2005; 33; 166-172.
12. Lei JY, Bourne PA, diSant'Agnese PA et al. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver. Am. J. Clin. Pathol. 2006; 125; 519-525.
13. Gu K, Shah V, Ma C et al. Cytoplasmic immunoreactivity of thyroid transcription factor-1 (clone 8G7G3/1) in hepatocytes: true positivity or cross-reaction? Am. J. Clin. Pathol. 2007; 128; 382-388.
14. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19; 403-410.
15. Tsang JY, Lai MW, Wong KH et al. alphaB-crystallin is a useful marker for triple negative and basal breast cancers. Histopathology 2012; 61; 378-386.
16. Zhang PL, Gao HG, Pasha TL et al. TTF-1 expresison in ovarian and uterine epithelial neoplasia and its potential significance, antibodies and different secondary detection systems. Int. J. Gynecol. Pathol. 2009; 28; 10-18.
17. Holzinger A, Dingle S, Bejarano PA et al. Monoclonal antibody to thyroid transcription factor-1: production, characterization and usefulness in tumor diagnosis. Hybridoma 1996; 15; 49-53.
18. Luo MH, Huang YH, Ni YB et al. Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas. Hum. Pathol. 2013; 44; 1241-1250.